Diagnostic Performance of Breast-Specific Gamma Imaging (BSGI) for Breast Cancer: Usefulness of Dual-Phase Imaging with 99mTc-sestamibi

Nuclear Medicine and Molecular Imaging

Volumn 47, Issue 1, 2013, Pages 18-26

  Park, Ji Sun ^a   Lee, Ah Young ^a   Jung, Kyung Pyo ^a   Choi, Su Jung ^a   Lee, Seok Mo ^a   kyun Bae, Sang ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Breast; Breast cancer; Breast specific gamma imaging; Dual phase imaging; Technetium 99 m Sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; BREAST CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE;

EID: 84874205151     PISSN: 18693474     EISSN: 18693482     Source Type: Journal    
DOI: 10.1007/s13139-012-0176-2     Document Type: Article

References (24)

1. van Dijck JA, Verbeek AL, Hendriks JH, Holland R. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer. 1993; 72: 1933-8.
2. Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005; 103: 1898-905.
3. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology. 1992; 184: 613-7.
4. Ganott MA, Harris KM, Klaman HM, Keeling TL. Analysis of false-negative cancer cases identified with a mammography audit. Breast J. 1999; 5: 166-75.
5. Morton MJ, Whaley DH, Brandt KR, Amrami KK. Screening mammograms: interpretation with computer-aided detection-prospective evaluation. Radiology. 2006; 239: 375-83.
6. Williams MB, Pisano ED, Schnall MD, Fajardo LL. Future directions in imaging of breast diseases. Radiology. 1998; 206: 297-300.
7. Kopans DB. The positive predictive value of mammography. AJR Am J Roentgenol. 1992; 158: 521-6.
8. Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology. 2008; 247: 651-7.
9. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High-resolution scintimammography: a pilot study. J Nucl Med. 2002; 43: 909-15.
10. Brem RF, Petrovitch I, Rapelyea JA, Young H, Teal C, Kelly T. Breast-specific gamma imaging with 99mTc sestamibi and magnetic resonance imaging in the diagnosis of breast cancer-a comparative study. Breast J. 2007; 13: 465-9.
11. Tafreshi NK, Kumar V, Morse DL, Gatenby RA. Molecular and functional imaging of breast cancer. Cancer Control. 2010; 17: 143-55.
12. Schillaci O, Buscombe JR. Breast scintigraphy today: indications and limitations. Eur J Nucl Med Mol Imaging. 2004; 31 Suppl 1: 35-45.
13. Liberman M, Sampalis F, Mulder DS, Sampalis JS. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Res Treat. 2003; 80: 115-26.
14. Brem RF, Kieper DA, Rapelyea JA, Majewski S. Evaluation of a high-resolution, breast-specific, small-field-of-view gamma camera for the detection of breast cancer. Nucl Instrum Meth Phys Res A. 2003; 497: 39-45.
15. Brem RF, Shahan C, Rapleyea JA, Donnelly CA, Rechtman LR, Kidwell AB, et al. Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol. 2010; 17: 735-43.
16. Brem RF, Rapelyea JA, Zisman G, Mohtashemi K, Raub J, Teal CB, et al. Occult breast cancer: Scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology. 2005; 237: 274-80.
17. Brem RF, Fishman M, Rapelyea JA. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study. Acad Radiol. 2007; 14: 945-50.
18. Brem RF, Michener KH, Zawistowski G. Approaches to improving breast cancer diagnosis using a high resolution, breast specific gamma camera. Phys Med. 2006; 21 Suppl 1: 17-9.
19. 99mTc sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med. 1994; 21: 984-7.
20. Sung Mo Hur SHK, Lee SK, Kim WW, Choi JH, Kim S, Lee S-J, et al. The preoperative role of breast-specific gamma imaging for the breast cancer patients: In comparison with conventional imaging modality. J Breast Cancer. 2010; 13: 198-205.
21. 99mTc MIBI scintimammogram in the evaluation of patients with palpable breast lesions in comparison with mammogram: Preliminary result. Nucl Med Mol Imaging. 2009; 43: 48-54.
22. 99mTc MIBI scintimammography. Anticancer Res. 1997; 17: 1631-4.
23. Reporting BI. Data System. Breast Imaging Atlas. 4th ed. Reston: American College of Radiology. 2003.
24. Goldsmith SJ, Parsons W, Guiberteau MJ, Stern LH, Lanzkowsky L, Weigert J, et al. SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1. 0. J Nucl Med Technol. 2010; 38: 219-24.